These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Cytomegalovirus disease prophylaxis in renal transplantation by high dose oral acyclovir: efficacy and limits. Bertoni E; Rosati A; Zanazzi M; Moscarelli L; Di Maria L; Piperno R; Orsi A; Parri F; Dedola G; Salvadori M Transplant Proc; 1998 Aug; 30(5):2094. PubMed ID: 9723402 [No Abstract] [Full Text] [Related]
36. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection. Reischig T; Jindra P; Svecová M; Kormunda S; Opatrný K; Treska V J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113 [TBL] [Abstract][Full Text] [Related]
37. Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients. Ho WG; Winston DJ; Champlin RE Transplant Proc; 1989 Feb; 21(1 Pt 3):3103-6. PubMed ID: 2539690 [No Abstract] [Full Text] [Related]
38. Successful treatment of cytomegalovirus disease with 9-(1,3-dihydroxy-2-propoxymethyl guanine). de Hemptinne B; Lamy ME; Salizzoni M; Cornu C; Mostin J; Fevery J; De Groote V; Otte JB Transplant Proc; 1988 Feb; 20(1 Suppl 1):652-5. PubMed ID: 2831645 [No Abstract] [Full Text] [Related]
39. Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis. Anglicheau D; Lautrette A; Scieux C; Thervet E; Martinez F; Flamant M; Morinet F; Legendre C Transplant Proc; 2002 Nov; 34(7):2826-7. PubMed ID: 12431624 [No Abstract] [Full Text] [Related]